A detailed history of Ntb Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Ntb Financial Corp holds 1,350 shares of LLY stock, worth $985,135. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,350
Previous 1,350 -0.0%
Holding current value
$985,135
Previous $387,000 13.18%
% of portfolio
0.35%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $5,867 - $7,291
-25 Reduced 1.82%
1,350 $387,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $309,168 - $383,680
1,375 New
1,375 $380,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $693B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ntb Financial Corp Portfolio

Follow Ntb Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntb Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ntb Financial Corp with notifications on news.